BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 844428)

  • 1. [Theophylline blood levels after administration of Euphyllin retard (author's transl)].
    Ahrens J
    Dtsch Med Wochenschr; 1977 Apr; 102(13):482-6. PubMed ID: 844428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative examination of theophylline-serum-concentrations and bronchospasmolytic effect of cholintheophyllinate (euspirax) and theophyllin-aethylendiamine (euphyllin retard) in patients with obstructive airway diseases (author's transl)].
    Wettengel R; Oellerich M; Schnitker J
    Prax Klin Pneumol; 1979 Nov; 33(11):1125-31. PubMed ID: 523424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lung functions and blood levels after parenteral administration of theophylline-ethylenediamine (author's transl)].
    Wiessmann KJ; Schulz HU
    Dtsch Med Wochenschr; 1977 Dec; 102(52):1916-20. PubMed ID: 598301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Euphyllin retard and "exercise-induced" asthma].
    Scherrer M; Bachofen H; Kyd K; Ahrens J; Röthlisberger U
    Schweiz Med Wochenschr; 1980 Jun; 110(25):985-9. PubMed ID: 7423136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of 2 theophylline delayed-action preparations of different galenic forms].
    Hirsch H
    Wien Med Wochenschr; 1983 Aug; 133(15-16):403-8. PubMed ID: 6636797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption of sustained-release theophylline tablets.
    Fagerström PO; Heintz L
    Int J Clin Pharmacol Ther Toxicol; 1983 Jul; 21(7):359-62. PubMed ID: 6885207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A single dose of theophylline in the evening in chronic obstructive airway disease. Serum concentration and lung function parameter].
    Kaik G
    Fortschr Med; 1984 Nov; 102(43):1120-2. PubMed ID: 6510864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of an oral aminophylline compound with protracted activity on respiratory resistance and blood gases in obstructive respiratory diseases (author's transl)].
    Dorow P
    Arzneimittelforschung; 1978; 28(5):853-6. PubMed ID: 373776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Absolute bioavailability of theophylline (Euphylline)].
    Somogyi A; Gugler R
    Fortschr Med; 1980 Nov; 98(43):1707-10. PubMed ID: 7450653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of theophylline-ethylenediamine in obstructive lung disease (author's transl)].
    Brossmann D; Ruf G; Wiessmann KJ
    Dtsch Med Wochenschr; 1980 Mar; 105(12):410-3. PubMed ID: 7363785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of steady state serum theophylline concentrations in healthy volunteers after dosing with Euphyllin retard and PulmiDur.
    Karlsson S; Lührmann B; Bahner ML; Schulz HU
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):342-6. PubMed ID: 3623739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminophylline injection and theophylline tablets: Acute response in partially reversible chronic airway obstruction.
    Freitag A
    Med J Aust; 1976 Apr; 1(14):478-9. PubMed ID: 933924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R
    Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of long-term oral administration of a bronchodilator, a sustained-release aminophylline preparation, on pulmonary function (author's transl)].
    Wiessmann KJ
    Dtsch Med Wochenschr; 1975 Nov; 100(48):2482-6. PubMed ID: 1201724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of proxyphylline in chronic obstructive pulmonary disease (author's transl)].
    Geisler LS; Thiel H; Förster OB; Rohner HG
    Dtsch Med Wochenschr; 1980 Jun; 105(25):894-7. PubMed ID: 7408664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of morning or evening administration on absorption of theophylline.
    Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations of theophylline and quinine in healthy volunteers following oral administration of a fixed drug combination.
    Dieterich HA; Messer W; Jaehnchen E
    Arzneimittelforschung; 1984; 34(4):520-2. PubMed ID: 6540112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.
    Jenne JW; Wyze MS; Rood FS; MacDonald FM
    Clin Pharmacol Ther; 1972; 13(3):349-60. PubMed ID: 5026376
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum theophylline levels in asthmatic children after oral administration of a slow-release aminophylline preparation (Phyllocontin Continus tablets).
    McKenzie S; Baillie E
    J Int Med Res; 1979; 7 Suppl 1():22-7. PubMed ID: 437305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.